MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Incidence of Depression in the Caregivers of Parkinson’s Disease Patients

S. Soleimani, M. Salari, F. Hojjati Pour (Tehran, Islamic Republic of Iran)

Meeting: 2024 International Congress

Abstract Number: 596

Keywords: Depression, Parkinson’s

Category: Quality Of Life/Caregiver Burden in Movement Disorders

Objective: To evaluate the impact of caring for individuals with Parkinson’s disease on caregivers’ social activities and mental health, and to assess depression and quality of life in caregivers.

Background: Parkinson’s disease, a neurodegenerative disorder, manifests through the degeneration of dopaminergic neurons in the Substantia Nigra. Common risk factors include age, male gender, and environmental influences. While the precise cause remains elusive in most cases, genetic factors play a role. Care for Parkinson’s patients primarily falls on family members and partners, impacting caregivers’ social lives and mental health. The research underscores the correlation between caregiving and heightened levels of depression, with potential consequences including an accelerated decline in physical and cognitive function and reduced quality of life.

Method: In this cross-sectional study, we used the Hamilton Depression Rating Scale (HDRS) to assess mental health among companions of Parkinson’s disease patients. Participants were selected from companions accompanying Parkinson’s patients to the clinic during a specified period. Informed consent was obtained from all participants in the study.

Data collected from the questionnaires were entered into statistical software for analysis, ensuring accuracy and consistency during the data entry process. Statistical tests and techniques, including descriptive statistics, were employed to analyze the data. The findings derived from the statistical analysis were interpreted, focusing on identifying patterns, correlations, and associations between caregiver burden, mental health outcomes, and relevant demographic or clinical variables.

Results: A total of 99 subjects with a mean age of 46.41±14.085 were evaluated, 58.6% of them were women, 9.1% already had a history of mental health problems and 11.1% had a positive family history of depression. the evaluated depression severity based on the HDRS scores is demonstrated in Figure 1.

Conclusion: Interventions such as social support and caregiver education have shown promise in delaying adverse outcomes, prompting further investigation into their efficacy for Parkinson’s patients’ caregivers.

Figure 1

Figure 1

To cite this abstract in AMA style:

S. Soleimani, M. Salari, F. Hojjati Pour. Incidence of Depression in the Caregivers of Parkinson’s Disease Patients [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/incidence-of-depression-in-the-caregivers-of-parkinsons-disease-patients/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/incidence-of-depression-in-the-caregivers-of-parkinsons-disease-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley